Zhejiang AngLiKang Pharmaceutical CO.,LTD. (SHE:002940)

China flag China · Delayed Price · Currency is CNY
27.81
+0.31 (1.13%)
Jun 12, 2026, 3:04 PM CST
Market Cap5.45B +99.4%
Revenue (ttm)1.42B -3.8%
Net Income127.19M +87.0%
EPS0.63 +90.8%
Shares Out 196.11M
PE Ratio44.09
Forward PEn/a
Dividend0.30 (1.09%)
Ex-Dividend DateNov 24, 2025
Volume13,642,500
Open29.70
Previous Close27.50
Day's Range27.10 - 29.70
52-Week Range25.50 - 68.80
Beta0.72
Analystsn/a
Price Targetn/a
Earnings DateAug 28, 2026

About SHE:002940

Zhejiang AngLiKang Pharmaceutical CO.,LTD., a pharmaceutical company, engages in manufacturing APIs and pharmaceutical preparations for oral cephalosporins, cardiovascular, and kidney diseases. The company also offers products in the areas of anti-infection, cardiovascular, urinary system (nephropathy), anesthesia and pain, and anti-androgen. The company was founded in 2001 and is based in Shengzhou, China. [Read more]

Sector Healthcare
Founded 2001
Employees 1,275
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 002940
Full Company Profile

Financial Performance

In 2025, SHE:002940's revenue was 1.42 billion, a decrease of -7.35% compared to the previous year's 1.54 billion. Earnings were 125.44 million, an increase of 56.15%.

Financial Statements